- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-1-1-mer
- Ligands
- 3 x LBN: 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine(Non-covalent)
- 3 x FAD: FLAVIN-ADENINE DINUCLEOTIDE(Non-covalent)
FAD.2: 13 residues within 4Å:- Chain A: L.126, V.129, Y.130, G.133, Q.140, R.161, K.162, G.165, L.233, S.237, H.251, Q.254, S.255
7 PLIP interactions:7 interactions with chain A- Hydrophobic interactions: A:L.126, A:L.233
- Hydrogen bonds: A:Q.140, A:S.237
- Salt bridges: A:R.161, A:H.251, A:K.305
FAD.6: 12 residues within 4Å:- Chain B: L.126, V.129, Y.130, G.133, R.161, K.162, G.165, L.233, S.237, H.251, Q.254, S.255
7 PLIP interactions:7 interactions with chain B- Hydrophobic interactions: B:L.126, B:L.233
- Hydrogen bonds: B:S.237, B:Q.254
- Salt bridges: B:R.161, B:R.161, B:H.251
FAD.8: 10 residues within 4Å:- Chain C: L.126, V.129, Y.130, R.161, K.162, G.165, L.233, S.237, H.251, Q.254
7 PLIP interactions:7 interactions with chain C- Hydrophobic interactions: C:L.126, C:L.233
- Hydrogen bonds: C:R.161, C:S.237, C:Q.254
- Salt bridges: C:R.161, C:K.305
- 3 x HEM: PROTOPORPHYRIN IX CONTAINING FE(Non-covalent)
HEM.4: 13 residues within 4Å:- Chain A: K.116, P.119, S.122, H.175, A.176, S.179, G.223, I.224, L.227, H.268, A.269, F.272, T.290
12 PLIP interactions:12 interactions with chain A,- Hydrophobic interactions: A:P.119, A:P.119, A:A.176, A:I.224, A:L.227, A:A.269, A:F.272
- Hydrogen bonds: A:Y.182
- Salt bridges: A:K.116, A:K.116
- Metal complexes: A:H.175, A:H.268
HEM.7: 14 residues within 4Å:- Chain B: K.116, P.119, H.175, A.176, S.179, G.223, I.224, L.227, L.230, H.268, A.269, F.272, T.290, F.291
11 PLIP interactions:11 interactions with chain B,- Hydrophobic interactions: B:P.119, B:A.176, B:I.224, B:L.227, B:L.230, B:A.269, B:F.272
- Salt bridges: B:K.116, B:K.116
- Metal complexes: B:H.175, B:H.268
HEM.9: 12 residues within 4Å:- Chain C: K.116, P.119, H.175, A.176, S.179, G.223, I.224, L.227, H.268, F.272, T.290, F.291
9 PLIP interactions:9 interactions with chain C,- Hydrophobic interactions: C:P.119, C:A.176, C:I.224, C:L.227, C:F.272
- Salt bridges: C:K.116, C:K.116
- Metal complexes: C:H.175, C:H.268
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Nolan-Stevaux, O. et al., AMG 509 (Xaluritamig), an Anti-STEAP1 XmAb 2+1 T-cell Redirecting Immune Therapy with Avidity-Dependent Activity against Prostate Cancer. Cancer Discov (2024)
- Release Date
- 2023-11-22
- Peptides
- Metalloreductase STEAP1: ABC
AMG 509 anti-STEAP1 Fab, heavy chain: D
AMG 509 anti-STEAP1 Fab, light chain: E - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
HE
L - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-1-1-mer
- Ligands
- 3 x LBN: 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine(Non-covalent)
- 3 x FAD: FLAVIN-ADENINE DINUCLEOTIDE(Non-covalent)
- 3 x HEM: PROTOPORPHYRIN IX CONTAINING FE(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Nolan-Stevaux, O. et al., AMG 509 (Xaluritamig), an Anti-STEAP1 XmAb 2+1 T-cell Redirecting Immune Therapy with Avidity-Dependent Activity against Prostate Cancer. Cancer Discov (2024)
- Release Date
- 2023-11-22
- Peptides
- Metalloreductase STEAP1: ABC
AMG 509 anti-STEAP1 Fab, heavy chain: D
AMG 509 anti-STEAP1 Fab, light chain: E - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
HE
L - Membrane
-
We predict this structure to be a membrane protein.